Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Nona Biosciences Enters into HCAb Based Antibody Discovery Collaboration Agreement with Mythic Therapeutics
Nona Biosciences, a wholly-owned subsidiary of HBM Holdings Limited committed to cutting-edge technology innovations, and […]
Adiso Therapeutics Announces the Appointment of Srikar Guntaka, M.D., as Medical Director
Adiso Therapeutics, a clinical-stage biotechnology company committed to creating medicines that treat inflammatory diseases and […]
Prokarium Announces $30 Million Financing to Deliver Lead Program into Clinic and Build Novel Therapeutic Platform
Prokarium, a biopharmaceutical company leading the oncology field of microbial immunotherapy, has raised $30 million […]
Adrestia Therapeutics Partners with Leading Patient Advocacy Groups to Form Ataxia Telangiectasia Research Consortium
Adrestia Therapeutics, a leader in synthetic rescue therapies for genetic diseases, has announced it has […]
Tioga Cardiovascular Closes $30M in Series C Financing
Tioga Cardiovascular, a Shifamed portfolio company that aims to redefine structural heart valve replacement, announced […]
The Mark Foundation for Cancer Research Announces More Than $2 Million in Funding for Two New Drug Discovery Awards for Pancreatic Cancer and Anticancer Therapeutics
The Mark Foundation for Cancer Research announced the latest recipients of its Drug Discovery Award, […]
Toragen Announces Appointment of Chief Scientific Officer
Toragen, a San Diego-based biotechnology company focused on developing, repurposing and commercializing uniquely selective drugs […]
First Citizens Bank Provides $31.2 Million for Acquisition of Cancer Treatment Center in Columbia, South Carolina
First Citizens Bank today announced that its Healthcare Finance group, part of the CIT division, […]
Roche Expands Collaboration with Janssen to Advance Personalised Healthcare Through Companion Diagnostics
Roche today announced that it has expanded its collaboration with Janssen Biotech Inc. (Janssen) to […]
ReviR Therapeutics and Asieris Pharmaceuticals Enter into Agreement to Discover Oncology Therapeutics
ReviR Therapeutics, a privately held developer of a suite of small molecule RNA-targeting technologies for […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more